Literature DB >> 9606143

Tandem immobilized metal-ion affinity chromatography/immunoaffinity purification of His-tagged proteins--evaluation of two anti-His-tag monoclonal antibodies.

K M Müller1, K M Arndt, K Bauer, A Plückthun.   

Abstract

A tag comprising four to six histidines genetically fused to the protein of interest (His-tag) has been widely used to purify proteins by immobilized metal-ion affinity chromatography (IMAC). Here we report the utilization of the same tag twice in series, first for IMAC and subsequently for immunoaffinity purification. Both steps are based on completely different physical principles and can therefore remove different contaminants. Two anti-His-tag antibodies (3D5 and PentaHis) were characterized for their binding and elution properties using the BIAcore surface plasmon resonance biosensor. The dissociation constant of the PentaHis antibody was determined to be 1 x 10(-8) M and for the 3D5 antibody 3.4 x 10(-7) M at pH 7.4. Imidazole in the sample did interfere with binding, whereas chelating agents such as EDTA and high salt did not. The antibody 3D5 was coupled to a column matrix and used for a coupled two-step purification, in which the IMAC column is eluted with EDTA and the eluent is loaded directly on the immunoaffinity column. This method may constitute a very general procedure to purify proteins to near homogeneity without the need to tailor conditions individually, and it may thus be very attractive for high-throughput screening programs and for developing general protocols for clinical grade material.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606143     DOI: 10.1006/abio.1998.2606

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  9 in total

1.  Conversion of scFv peptide-binding specificity for crystal chaperone development.

Authors:  Jennifer C Pai; Jeffrey A Culver; Jason E Drury; Rakesh S Motani; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2011-01-08       Impact factor: 1.650

2.  Engineering Escherichia coli BL21(DE3) derivative strains to minimize E. coli protein contamination after purification by immobilized metal affinity chromatography.

Authors:  Carine Robichon; Jianying Luo; Thomas B Causey; Jack S Benner; James C Samuelson
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

3.  A new class of proteins capable of binding transition metals.

Authors:  P E Dykema; P R Sipes; A Marie; B J Biermann; D N Crowell; S K Randall
Journal:  Plant Mol Biol       Date:  1999-09       Impact factor: 4.076

4.  Protein kinase C-mediated phosphorylation of Kv beta 2 in adult rat brain.

Authors:  Xintao Wang; Jie Zhang; Stan M Berkowski; Heather Knowleg; A B Chandramouly; Martha Downens; Michael B Prystowsky
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

5.  Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112.

Authors:  Liwei Chen; Daniele Pernazza; Latanya M Scott; Harshani R Lawrence; Yuan Ren; Yunting Luo; Xin Wu; Shen-Shu Sung; Wayne C Guida; Said M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

6.  Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins.

Authors:  Miguel Angel Muñoz-Alía; Stephen J Russell
Journal:  Viruses       Date:  2019-07-27       Impact factor: 5.048

Review 7.  Challenges and opportunities in the purification of recombinant tagged proteins.

Authors:  Ana Sofia Pina; Christopher R Lowe; Ana Cecília A Roque
Journal:  Biotechnol Adv       Date:  2013-12-12       Impact factor: 14.227

8.  His-tag protein monitoring by a fast mix-and-measure immunoassay.

Authors:  Thomas Kreisig; Agneta A Prasse; Kristin Zscharnack; Daniela Volke; Thole Zuchner
Journal:  Sci Rep       Date:  2014-07-08       Impact factor: 4.379

Review 9.  Recombinant viral proteins for use in diagnostic ELISAs to detect virus infection.

Authors:  Kelly-Anne Spencer; Fernando A Osorio; Julian A Hiscox
Journal:  Vaccine       Date:  2007-03-06       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.